Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants

Kristi L. Watterberg, Michele L. Shaffer, Mary J. Mishefske, Corinne L. Leach, Mark C. Mammel, Robert J. Couser, Soraya Abbasi, Cynthia H. Cole, Susan W Aucott, Elizabeth H. Thilo, Henry J. Rozycki, Conra Backstrom Lacy

Research output: Contribution to journalArticle

Abstract

BACKGROUND. Low cortisol concentrations in premature infants have been correlated with increased severity of illness, hypotension, mortality, and development of bronchopulmonary dysplasia. A total of 360 mechanically ventilated infants with a birth weight of 500 to 999 g were enrolled in a randomized, multicenter trial of prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia. Mortality and bronchopulmonary dysplasia were decreased in the hydrocortisone-treated patients exposed to chorioamnionitis. We now report outcomes at 18 to 22 months' corrected age. PATIENTS AND METHODS. Surviving infants were evaluated with standardized neurologic examination and Bayley Scales of Infant Development-II. Neurodevelopmental impairment was defined as a Mental Developmental Index or Psychomotor Developmental Index of

Original languageEnglish (US)
Pages (from-to)40-48
Number of pages9
JournalPediatrics
Volume120
Issue number1
DOIs
StatePublished - Jul 2007

Fingerprint

Extremely Low Birth Weight Infant
Bronchopulmonary Dysplasia
Hydrocortisone
Growth
Chorioamnionitis
Adrenal Insufficiency
Mortality
Neurologic Examination
Child Development
Birth Weight
Premature Infants
Hypotension
Multicenter Studies
Therapeutics

Keywords

  • Cerebral palsy
  • Developmental assessment
  • Extremely preterm infant
  • Hydrocortisone
  • Postnatal steroid therapy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Watterberg, K. L., Shaffer, M. L., Mishefske, M. J., Leach, C. L., Mammel, M. C., Couser, R. J., ... Lacy, C. B. (2007). Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics, 120(1), 40-48. https://doi.org/10.1542/peds.2006-3158

Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. / Watterberg, Kristi L.; Shaffer, Michele L.; Mishefske, Mary J.; Leach, Corinne L.; Mammel, Mark C.; Couser, Robert J.; Abbasi, Soraya; Cole, Cynthia H.; Aucott, Susan W; Thilo, Elizabeth H.; Rozycki, Henry J.; Lacy, Conra Backstrom.

In: Pediatrics, Vol. 120, No. 1, 07.2007, p. 40-48.

Research output: Contribution to journalArticle

Watterberg, KL, Shaffer, ML, Mishefske, MJ, Leach, CL, Mammel, MC, Couser, RJ, Abbasi, S, Cole, CH, Aucott, SW, Thilo, EH, Rozycki, HJ & Lacy, CB 2007, 'Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants', Pediatrics, vol. 120, no. 1, pp. 40-48. https://doi.org/10.1542/peds.2006-3158
Watterberg, Kristi L. ; Shaffer, Michele L. ; Mishefske, Mary J. ; Leach, Corinne L. ; Mammel, Mark C. ; Couser, Robert J. ; Abbasi, Soraya ; Cole, Cynthia H. ; Aucott, Susan W ; Thilo, Elizabeth H. ; Rozycki, Henry J. ; Lacy, Conra Backstrom. / Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. In: Pediatrics. 2007 ; Vol. 120, No. 1. pp. 40-48.
@article{28c149d5f0424c4498d5f58b0658c5e8,
title = "Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants",
abstract = "BACKGROUND. Low cortisol concentrations in premature infants have been correlated with increased severity of illness, hypotension, mortality, and development of bronchopulmonary dysplasia. A total of 360 mechanically ventilated infants with a birth weight of 500 to 999 g were enrolled in a randomized, multicenter trial of prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia. Mortality and bronchopulmonary dysplasia were decreased in the hydrocortisone-treated patients exposed to chorioamnionitis. We now report outcomes at 18 to 22 months' corrected age. PATIENTS AND METHODS. Surviving infants were evaluated with standardized neurologic examination and Bayley Scales of Infant Development-II. Neurodevelopmental impairment was defined as a Mental Developmental Index or Psychomotor Developmental Index of",
keywords = "Cerebral palsy, Developmental assessment, Extremely preterm infant, Hydrocortisone, Postnatal steroid therapy",
author = "Watterberg, {Kristi L.} and Shaffer, {Michele L.} and Mishefske, {Mary J.} and Leach, {Corinne L.} and Mammel, {Mark C.} and Couser, {Robert J.} and Soraya Abbasi and Cole, {Cynthia H.} and Aucott, {Susan W} and Thilo, {Elizabeth H.} and Rozycki, {Henry J.} and Lacy, {Conra Backstrom}",
year = "2007",
month = "7",
doi = "10.1542/peds.2006-3158",
language = "English (US)",
volume = "120",
pages = "40--48",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants

AU - Watterberg, Kristi L.

AU - Shaffer, Michele L.

AU - Mishefske, Mary J.

AU - Leach, Corinne L.

AU - Mammel, Mark C.

AU - Couser, Robert J.

AU - Abbasi, Soraya

AU - Cole, Cynthia H.

AU - Aucott, Susan W

AU - Thilo, Elizabeth H.

AU - Rozycki, Henry J.

AU - Lacy, Conra Backstrom

PY - 2007/7

Y1 - 2007/7

N2 - BACKGROUND. Low cortisol concentrations in premature infants have been correlated with increased severity of illness, hypotension, mortality, and development of bronchopulmonary dysplasia. A total of 360 mechanically ventilated infants with a birth weight of 500 to 999 g were enrolled in a randomized, multicenter trial of prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia. Mortality and bronchopulmonary dysplasia were decreased in the hydrocortisone-treated patients exposed to chorioamnionitis. We now report outcomes at 18 to 22 months' corrected age. PATIENTS AND METHODS. Surviving infants were evaluated with standardized neurologic examination and Bayley Scales of Infant Development-II. Neurodevelopmental impairment was defined as a Mental Developmental Index or Psychomotor Developmental Index of

AB - BACKGROUND. Low cortisol concentrations in premature infants have been correlated with increased severity of illness, hypotension, mortality, and development of bronchopulmonary dysplasia. A total of 360 mechanically ventilated infants with a birth weight of 500 to 999 g were enrolled in a randomized, multicenter trial of prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia. Mortality and bronchopulmonary dysplasia were decreased in the hydrocortisone-treated patients exposed to chorioamnionitis. We now report outcomes at 18 to 22 months' corrected age. PATIENTS AND METHODS. Surviving infants were evaluated with standardized neurologic examination and Bayley Scales of Infant Development-II. Neurodevelopmental impairment was defined as a Mental Developmental Index or Psychomotor Developmental Index of

KW - Cerebral palsy

KW - Developmental assessment

KW - Extremely preterm infant

KW - Hydrocortisone

KW - Postnatal steroid therapy

UR - http://www.scopus.com/inward/record.url?scp=33947193013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947193013&partnerID=8YFLogxK

U2 - 10.1542/peds.2006-3158

DO - 10.1542/peds.2006-3158

M3 - Article

C2 - 17606560

AN - SCOPUS:33947193013

VL - 120

SP - 40

EP - 48

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -